On the sidelines of Abu Dhabi Global Health Week 2025.. Deputy Prime Minister and Minister of Health witnesses the signing of a letter of intent with AstraZeneca to localize advanced molecular genetic testing
On the sidelines of Abu Dhabi Global Health Week 2025..
Deputy Prime Minister and Minister of Health witnesses the signing of a letter of intent with AstraZeneca to localize advanced molecular genetic testing
=============
Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, witnessed the signing ceremony of a letter of intent between the Ministry and AstraZeneca, on the sidelines of Abu Dhabi Global Health Week 2025, held in the United Arab Emirates from 15 to 17 April.
Dr. Hossam Abdel Ghaffar, the official spokesperson of the Ministry of Health and Population, explained that the letter of intent aims to increase the localization of diagnostic tests for the detection of immune, genetic and cancerous diseases, which are currently performed abroad, as well as working to increase the detection of cases of cancer, immune and genetic diseases at early stages.
Abdel Ghaffar added that the letter of intent helps ensure the quality of the medical services provided by the Egyptian health system, reduces the time needed to obtain results, and lowers the cost and risks of transporting samples abroad, in addition to strengthening cooperation between government medical institutions and the private sector to improve the services provided for patient care.
Abdel Ghaffar pointed out that the letter includes working to localize diagnostic tests for the detection of cancers, including lung cancer, breast cancer, gastrointestinal tumors and blood cancers, to detect the genetic mutations associated with them, in addition to localizing diagnostic tests for the detection of immune and genetic diseases.
The letter was signed by Dr. Mohamed Hassany, Assistant Minister for Public Health Projects and Initiatives, and Dr. Hatem Wardany, Chairman of the Board of AstraZeneca.
On the sidelines of the signing of the letter of intent, Dr. Khaled Abdel Ghaffar met with the leadership of global AstraZeneca, represented by Mr. Michel Demaré, Chairman of the Board of AstraZeneca; Ms. Iskra Reic, Executive Vice President, International; Dr. Belen Engeso, Regional Vice President for the Middle East and Africa; and Dr. Hatem Wardany, Chairman of the Board of AstraZeneca Egypt, to discuss ways of strengthening ongoing cooperation with the private sector, to ensure the readiness and sustainability of the health care system in Egypt, provide awareness and early screening services, raise the competence of service providers, and provide the latest treatments, in line with the recommendations of international medical bodies, particularly in the file of rare diseases and lung health, helping to achieve health equity for all citizens, in line with the goals of "Egypt Vision 2030".